ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 1.100
0.00 (0.00%)
At close: Oct 29, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 33.43 million as of October 30, 2026. It is the 35,472nd most valuable company in the world and the 1,081st biggest in Canada. Its market cap has decreased by 76.22% in one year.
Market Cap
33.43M
Enterprise Value
32.92M
Revenue
n/a
Global Rank
Country Rank
#1,081 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 33.43M, an increase of 131.63%. That is a compound annual growth rate of 31.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 33.43M | -72.19% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 44.79M |
| Sharp Therapeutics | 43.26M |
| Medicenna Therapeutics | 41.07M |
| Microbix Biosystems | 40.41M |
| Sernova Biotherapeutics | 39.65M |
| BriaCell Therapeutics | 36.97M |
| MedMira | 35.09M |
| Sona Nanotech | 34.38M |